Hyojung Kim

7PUBLICATIONS
31CO-AUTHORS
Toxicology (incl. clinical toxicology)Pacific Peoples sport and physical activityPharmacogenomicsCondensed matter characterisation technique developmentAnimal neurobiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 28, 2021
Parkin interacting substrate phosphorylation by c-Abl drives dopaminergic neurodegeneration.

Hyojung Kim, Jeong-Yong Shin, Areum Jo

|Aug 28, 2021
Effects of 1α,25-Dihydroxyvitamin D3 on the Pharmacokinetics of Procainamide and Its Metabolite N-Acetylprocainamide, Organic Cation Transporter Substrates, in Rats with PBPK Modeling Approach.

Anusha Balla, Yoo-Seong Jeong, Hyo-Jung Kim

|Jul 29, 2021
PARIS farnesylation prevents neurodegeneration in models of Parkinson's disease.

Areum Jo, Yunjong Lee, Tae-In Kam

|Jan 14, 2021
Activation of the Akt1-CREB pathway promotes RNF146 expression to inhibit PARP1-mediated neuronal death.

Hyojung Kim, Jisoo Park, Hojin Kang

|Nov 26, 2020
Differential Effects of 1α,25-Dihydroxyvitamin D3 on the Expressions and Functions of Hepatic CYP and UGT Enzymes and Its Pharmacokinetic Consequences In Vivo.

Trang Nguyen Kieu Doan, Dang-Khoa Vo, Hyojung Kim

|Nov 17, 2020
Brain Endothelial P-Glycoprotein Level Is Reduced in Parkinson's Disease via a Vitamin D Receptor-Dependent Pathway.

Hyojung Kim, Jeong-Yong Shin, Yun-Song Lee

Pageof 2

Frequent Collaborators

7 joint publications

Yunjong Lee

2 joint publications

Sangwoo Ham

2 joint publications

Jeong-Yong Shin

2 joint publications

Joo-Ho Shin